AtriCure: Vanguard reports 7.22% ownership stake
The reported holdings include securities held by Vanguard funds and client accounts managed by the reporting business and specified affiliates.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AtriCure, Inc. (ATRC) is the issuer in an amended ownership disclosure by Vanguard Portfolio Management, which reported beneficial ownership of 3,676,303 shares, or 7.22% of the common stock, as of September 30, 2026. Vanguard reported sole voting power over 49,307 shares and sole dispositive power over 3,676,303 shares, with no shared voting or dispositive power. The disclosed holdings include securities held by Vanguard funds and client accounts over which Vanguard or identified affiliates exercise voting and/or dispositive power.
Key Figures
Key Terms
beneficially owned regulatory
Sole Voting Power regulatory
Sole Dispositive Power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.